When people become ill, they may seek medical attention through a professional that is able to diagnose and treat the specific condition. It may be chronic or acute, severe or mild, and may be caused by a chemical or a living organism, such as bacteria or a virus. All of these factors go into the treatment decision made by a physician, and in the case of infection or sexually transmitted disease, an antibiotic is usually utilized for treatment. One such antibiotic is ciprofloxacin, and ciprofloxacin for chlamydia, a sexually transmitted disease, has been proven effective yet has not been approved as a measure of treatment.
Chlamydia is a disease usually transmitted through sexual contact between human beings. Chlamydia trachomatis is the specific bacteria responsible for this sexually transmitted disease, and when this strain is given the opportunity to reproduce, it may become present in infectious quantities. This condition is characterized by specific symptoms, which may differ between the sexes. In males, chlamydia typically manifests itself in difficulty and pain during urination, inflammation of the urethra and penis, as well as unusual discharge. Women may experience no symptoms at all or have painful intercourse, inflamed reproductive organs, and difficulty urinating.
Ciprofloxacin for chlamydia has not yet been approved as a treatment modality as of 2011; however, a number of other antibiotic options exist. Among these are azithromycin and doxycycline as well as tetracycline and erythromycin. It is likely that ciprofloxacin for chlamydia will take a significant amount of time to be regularly utilized, potentially never becoming approved at all. This is due to the in-depth and time-consuming process of drug approval.
Although this process may appear to limit a number of treatments, it is also responsible for keeping safety a priority in prescription drug use. All drugs possess the potential for adverse side effects, and any possible effect should be explored in research settings before being approved for human use. The Food and Drug Administration of the United States oversees all activity related to the use of prescription drugs in that country.
When ciprofloxacin for chlamydia is used, it is generally done in a short-term, high-dosage manner. This, for example, may be 500 milligrams twice daily for three days. Due to the complexities involved in medication regulation and the constantly changing approvals, patients should consult a medical professional before making any decision.